Kiniksa Pharmaceuticals Announces Development of KPL-387 in Recurrent Pericarditis and Updates Corporate StrategyGlobeNewsWire • 02/25/25
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025GlobeNewsWire • 02/20/25
Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue GuidanceGlobeNewsWire • 01/13/25
Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/06/25
Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx ConferenceGlobeNewsWire • 11/26/24
Kiniksa Pharmaceuticals International, plc (KNSA) Q3 2024 Earnings Call TranscriptSeeking Alpha • 10/29/24
Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 10/29/24
Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio ExecutionGlobeNewsWire • 10/29/24
Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024GlobeNewsWire • 10/22/24
What Makes Kiniksa Pharmaceuticals (KNSA) a Good Fit for 'Trend Investing'Zacks Investment Research • 10/11/24
Wall Street Analysts Think Kiniksa Pharmaceuticals (KNSA) Could Surge 42.34%: Read This Before Placing a BetZacks Investment Research • 10/09/24
Kiniksa Pharmaceuticals (KNSA) is on the Move, Here's Why the Trend Could be SustainableZacks Investment Research • 09/20/24
Wall Street Analysts Believe Kiniksa Pharmaceuticals (KNSA) Could Rally 30.11%: Here's is How to TradeZacks Investment Research • 08/05/24
Kiniksa Pharmaceuticals, Ltd. (KNSA) Is Up 0.09% in One Week: What You Should KnowZacks Investment Research • 07/26/24
Recent Price Trend in Kiniksa Pharmaceuticals (KNSA) is Your Friend, Here's WhyZacks Investment Research • 07/26/24
Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2024 Earnings Call TranscriptSeeking Alpha • 07/23/24
Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 07/23/24
Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio ExecutionGlobeNewsWire • 07/23/24
Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024GlobeNewsWire • 07/16/24
Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren's DiseaseGlobeNewsWire • 07/09/24
Kiniksa Pharmaceuticals Sponsors American Heart Association's Addressing Recurrent Pericarditis InitiativeGlobeNewsWire • 06/17/24